AEON
AEON BIOPHARMA-A (AEON)
NYSE
$0.74+$0.006 (+0.89%)
Price as of Jun 03, 2026 7:51 PM EDT
  • $19.9M
    Market Cap
  • 27.24%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
3.3M
+71.78%
Gross Profit
0
N/A
0
N/A
0
+100.00%
-3.3M
+71.78%
Sales and Marketing Expense
12.2M
-10.52%
13.6M
+37.13%
9.9M
N/A
N/A
N/A
Research and Development Expense
-4.1M
-71.13%
-14.2M
+7.08%
-13.2M
N/A
N/A
N/A
Depreciation and Amortization Expense
78,000
-19.59%
97,000
+115.56%
45,000
N/A
N/A
N/A
Total Operating Expenses
12.8M
+117.54%
-73.0M
-122.92%
318.4M
+9,475.46%
3.3M
+71.78%
Operating Profit
-12.8M
-117.54%
73.0M
+122.92%
-318.4M
+9,475.46%
-3.3M
+71.78%
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
3.7M
+4,551.53%
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
0
N/A
0
N/A
0
-100.00%
3.7M
+4,551.53%
Total Nonoperating Income and Expense
-26.4M
-14.72%
-31.0M
+462.05%
-5.5M
-152.08%
10.6M
+4.41%
Income before Taxes
-39.2M
-193.37%
42.0M
+112.97%
-324.0M
-4,562.99%
7.3M
+474.94%
Income Taxes
0
N/A
0
N/A
0
-100.00%
883,329
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-39.2M
-193.37%
42.0M
+112.97%
-324.0M
-5,181.36%
6.4M
-22.26%
Net Income from Continuing Operations Applicable to Common
-39.2M
-193.37%
42.0M
+112.97%
-324.0M
-4,562.99%
7.3M
-11.49%
Basic EPS and Net Income
-3.95
-105.08%
77.74
+991.51%
-8.72
-1,068.89%
0.90
-13.46%
Diluted EPS and Net Income
-3.95
-105.42%
72.93
+936.35%
-8.72
-1,068.89%
0.90
-13.46%
Basic Weighted Average Shares
9.9M
+1,736.11%
540,360
-98.55%
37.2M
-61.53%
96.6M
+54.28%
Diluted Weighted Average Shares
9.9M
+1,622.66%
575,945
-98.45%
37.2M
-61.53%
96.6M
+54.28%
Balance Sheet
Cash and Cash Equivalents
3.0M
+23,023.08%
13,000
-99.75%
5.2M
+7,495.46%
67,909
-86.35%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
3.0M
+23,023.08%
13,000
-99.75%
5.2M
+7,495.46%
67,909
-86.35%
Total Current Assets
3.4M
+113.71%
1.6M
-74.45%
6.2M
+5,598.01%
109,196
-86.93%
Accumulated Depreciation
344,000
+28.84%
267,000
+57.06%
170,000
N/A
N/A
N/A
Property and Plant and Equipment and Net
162,000
-31.06%
235,000
-29.22%
332,000
N/A
N/A
N/A
Total Long-Term Assets
948,000
+3,168.97%
29,000
0.00%
29,000
-99.99%
279.4M
+1.17%
Total Assets
5.6M
+76.96%
3.1M
-54.10%
6.8M
-97.55%
279.5M
+0.92%
Income Taxes Payable
569,000
0.00%
569,000
0.00%
569,000
+93.25%
294,430
+47.22%
Total Short-Term Debt
N/A
N/A
N/A
N/A
70.9M
+47,144.00%
150,000
N/A
Total Current Liabilities
6.9M
-51.25%
14.1M
+8.43%
13.0M
+236.23%
3.9M
+365.02%
Total Long-Term Debt
34.6M
+196.00%
11.7M
-80.66%
60.4M
N/A
N/A
N/A
Total Long-Term Liabilities
19.0M
+716.81%
2.3M
+38.07%
1.7M
+152.18%
669,759
-90.93%
Total Liabilities
60.6M
+91.06%
31.7M
-80.17%
159.9M
+1,431.02%
10.4M
-41.59%
Retained Earnings
-470.8M
+9.09%
-431.6M
-8.87%
-473.6M
+4,901.27%
-9.5M
-44.17%
Total Stockholders Equity
-55.0M
-1,375,775.00%
4,000
+100.00%
-153.0M
+1,521.75%
-9.4M
-44.26%
Total Shares Outstanding
12.1M
-84.85%
79.9M
+115.02%
37.2M
+438.54%
6.9M
-50.00%
Cash Flow
Cash from Operating Activities
-17.3M
-14.71%
-20.3M
-22.19%
-26.1M
+2,557.35%
-981,428
-34.34%
Capital Expenditures
4,000
N/A
N/A
N/A
306,000
N/A
N/A
N/A
Cash from Investing Activities
-4,000
N/A
N/A
N/A
-306,000
-176.13%
401,925
+100.15%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
20.3M
+34.05%
15.1M
+8.19%
14.0M
+9,233.33%
150,000
-99.95%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-901.45%
-207.16%
841.19%
+471.76%
-226.27%
-9,974.47%
2.29%
N/A
Return on Equity
142.57%
+359.71%
-54.89%
-113.77%
398.76%
+924.58%
-48.36%
N/A
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
0.49
+338.35%
0.11
-76.43%
0.48
+1,596.80%
0.03
N/A
Cash Ratio
0.44
+48,322.22%
0.0009
-99.77%
0.40
+2,158.86%
0.02
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
-0.86
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
19.18
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow